IKBKB and arthritic joint disease: Collectively, our results show that SF-Cyld controls TAK1 kinase to prevent IKK2 and NF-κB hyperactivation but not Ripk1-mediated death, leading to deterioration of arthritic phenotype in TNF-dependent arthritis.